ProShare Advisors’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.26M	Sell	11,918 -2,166	-15%	-$192K	﹤0.01%	750
2025 Q4	$1.23M	Buy	14,084 +897	+7%	+$73.4K	﹤0.01%	773
2025 Q3	$876K	Sell	13,187 -2,189	-14%	-$124K	﹤0.01%	852
2025 Q2	$850K	Sell	15,376 -1,382	-8%	-$66.3K	﹤0.01%	877
2025 Q1	$810K	Sell	16,758 -3,699	-18%	-$155K	﹤0.01%	872
2024 Q4	$790K	Buy	20,457 +4,776	+30%	+$208K	﹤0.01%	1022
2024 Q3	$706K	Buy	15,681 +4,411	+39%	+$178K	﹤0.01%	936
2024 Q2	$391K	Sell	11,270 -3,075	-21%	-$90.1K	﹤0.01%	1119
2024 Q1	$415K	Buy	14,345 +1,206	+9%	+$32.8K	﹤0.01%	1199
2023 Q4	$301K	Buy	13,139 +1,957	+18%	+$34.2K	﹤0.01%	1374
2023 Q3	$187K	Buy	11,182 +427	+4%	+$8.29K	﹤0.01%	1494
2023 Q2	$297K	Buy	10,755 +1,869	+21%	+$46.8K	﹤0.01%	1277
2023 Q1	$204K	Buy	+8,886	New	+$149K	﹤0.01%	1435
2022 Q2	–	Sell	-13,399	Closed	-$317K	–	2051
2022 Q1	$317K	Sell	13,399 -3,090	-19%	-$87.1K	﹤0.01%	1588
2021 Q4	$564K	Buy	16,489 +597	+4%	+$18.9K	﹤0.01%	1363
2021 Q3	$282K	Sell	15,892 -2,729	-15%	-$116K	﹤0.01%	1593
2021 Q2	$836K	Buy	18,621 +3,254	+21%	+$107K	﹤0.01%	1140
2021 Q1	$398K	Buy	15,367 +2,492	+19%	+$63.1K	﹤0.01%	1609
2020 Q4	$260K	Buy	+12,875	New	+$277K	﹤0.01%	1706